Author:
Grooteman M. P. C.,Nubé M. J.,Blankestijn P. J.
Reference132 articles.
1. Agarwal R, Flynn J, Pogue V, Rahman M, Reisin E, Weir MR. Assessment and management of hypertension in patients on dialysis. J Am Soc Nephrol. 2014;25(8):1630–46.
2. Akoglu H, Dede F, Piskinpasa S, Falay MY, Odabas AR. Impact of low- or high-flux haemodialysis and online haemodiafiltration on inflammatory markers and lipid profile in chronic haemodialysis patients. Blood Purif. 2013;35(4):258–64.
3. Albalate RM, Perez GR, de Sequera OP, Alcazar AR, Corchete PE, Puerta CM, et al. Clinical application of ultracontrol(R): infusion volume and use with different dialyzers. Nefrologia. 2011;31(6):683–9.
4. Asano M, Thumma J, Oguchi K, Pisoni RL, Akizawa T, Akiba T, et al. Vascular access care and treatment practices associated with outcomes of arteriovenous fistula: international comparisons from the Dialysis Outcomes and Practice Patterns Study. Nephron Clin Pract. 2013;124(1-2):23–30.
5. Asci G, Tz H, Ozkahya M, Duman S, Demirci MS, Cirit M, et al. The impact of membrane permeability and dialysate purity on cardiovascular outcomes. J Am Soc Nephrol. 2013;24(6):1014–23.